Atherosclerosis endothelial activation quantification in vivo with fluorine magnetic resonance imaging and spectroscopy by Hua Pan et al.
ORAL PRESENTATION Open Access
Atherosclerosis endothelial activation
quantification in vivo with fluorine magnetic
resonance imaging and spectroscopy
Hua Pan*, Jacob Myerson, Xiaoxia Yang, Gregory Lanza, Samuel A Wickline
From 17th Annual SCMR Scientific Sessions
New Orleans, LA, USA. 16-19 January 2014
Background
Endothelial activation is one of the necessary initial steps
in the formation of atherosclerotic plaque that facilitates
immune cell recruitment and retention. To image and
quantify early markers of endothelial inflammation, we
recently developed a multiplexing peptide-based targeting
system for post-formulation functionalization of perfluoro-
carbon (19F) nanoparticles (PFC NP) that is intrinsically
quantifiable at a binding site based on magnetic resonance
spectroscopy. The approach is now demonstrated in vivo
to detect and quantify VCAM-1 in ApoE-/- mouse aorta.
Methods
VCAM-1 targeted PFC NPs were generated through
post-formulation strategy by using linker peptides.
Specific targeting has been validated in vitro by using
confocal imaging, 19F magnetic resonance spectroscopy
(MRS), and magnetic resonance imaging (MRI).
Quantification of endothelial activation in atherosclerosis
has been investigated by using ApoE-/- and control
C57-BL6 mice through MRS.
Results
Specific targeting to VCAM-1 in vitro to mouse endothe-
lial cells subjected to TNF-a stimulation was confirmed by
confocal imaging and magnetic resonance imaging (MRI),
and quantified by 19F magnetic resonance spectroscopy
(MRS) (11.7T) in comparison to a 19F calibration stan-
dard. Next, ApoE-/- and control C57-BL6 mice (n ≥3/
group) fed a western diet for 8 weeks, were injected i.v.
with VCAM-1 targeted or non-targeted nanoparticles.
After two hours, aortas were subjected ex vivo to MRS
analysis (11.7T) which revealed a 4.6-fold increase in the
amount of nanoparticles in aortas from the ApoE-/- mice
receiving VCAM-1 targeted nanoparticles as compared
with other groups (ApoE -/- mice: targeted vs non-tar-
geted - 8.22 ± 4.4 vs 1.78 ± 1.2 × 105 NPs/mm2, p < 0.05;
C57-BL6 mice: targeted vs non-targeted - 2.28 ± 1.24 vs
2.08 ± 0.98 × 107 NPs/mm2).
Conclusions
The use of 19F MRI/MRS together with a flexible and
rapid postformulation approach to creating ligand
targeted nanoparticulate contrast agents may enhance
the efficiency and breadth of molecular imaging of
atherosclerosis with MRI and enable quantification of
selected biomarker molecules that are important early
drivers of atherosclerosis.
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